Lior Zornitzki, Neta Sror, Amir Bar-Shai, Rotem Tellem, Shmuel Banai, Shir Frydman, Gil Bornstein, Ophir Freund
{"title":"晚期COPD和心力衰竭患者姑息治疗的利用不足:关联、差异和专家的作用。","authors":"Lior Zornitzki, Neta Sror, Amir Bar-Shai, Rotem Tellem, Shmuel Banai, Shir Frydman, Gil Bornstein, Ophir Freund","doi":"10.1177/17534666251364056","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Palliative care is essential for managing advanced chronic illnesses (ACI) but remains underused.</p><p><strong>Objectives: </strong>We aimed to evaluate the prevalence, associations, and outcomes of palliative care utilization (PCU) in patients with ACIs.</p><p><strong>Design: </strong>A prospective observational questionnaire-based study.</p><p><strong>Methods: </strong>The study included hospitalized patients with severe COPD (<i>n</i> = 53), advanced heart failure (HF; <i>n</i> = 56), or metastatic malignancy (<i>n</i> = 57). Participants were interviewed about their demographics, health status, PCU, and end-of-life decision-making.</p><p><strong>Results: </strong>A total of 166 subjects were included (median age: 77 years; 41% females), with a 1-year median of 2 hospital admissions. Subjects with COPD and HF had low rates of PCU compared to those with malignancy (6% and 11% vs 39%, <i>p</i> < 0.01). PCU occurred exclusively in patients who had visited a specialist (cardiologist, pulmonologist, or oncologist) before study inclusion. Patients with PCU were more aware of advance directives (71% vs 38%), signed advanced orders (23% vs 3%), and shared their end-of-life decisions with others (71% vs 29%). These differences remained significant after adjustment for prior specialist visits. Independent associations with PCU were self-identifying as non-religious (adjusted OR 3.41, 95% CI 1.2-9.9), above high-school education (AOR 2.84, 95% CI 1.1-7.3), and chronic pain (aOR 2.81, 95% CI 1.11-7.14), while COPD showed the opposite (aOR 0.25, 95% CI 0.07-0.96).</p><p><strong>Conclusion: </strong>Palliative care utilization is alarmingly low among patients with HF and COPD despite significant symptom burden. Specialists should advocate for PCU as their involvement could enhance end-of-life care planning, improve patient outcomes, and address current gaps in care.</p>","PeriodicalId":22884,"journal":{"name":"Therapeutic Advances in Respiratory Disease","volume":"19 ","pages":"17534666251364056"},"PeriodicalIF":3.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344236/pdf/","citationCount":"0","resultStr":"{\"title\":\"Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists.\",\"authors\":\"Lior Zornitzki, Neta Sror, Amir Bar-Shai, Rotem Tellem, Shmuel Banai, Shir Frydman, Gil Bornstein, Ophir Freund\",\"doi\":\"10.1177/17534666251364056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Palliative care is essential for managing advanced chronic illnesses (ACI) but remains underused.</p><p><strong>Objectives: </strong>We aimed to evaluate the prevalence, associations, and outcomes of palliative care utilization (PCU) in patients with ACIs.</p><p><strong>Design: </strong>A prospective observational questionnaire-based study.</p><p><strong>Methods: </strong>The study included hospitalized patients with severe COPD (<i>n</i> = 53), advanced heart failure (HF; <i>n</i> = 56), or metastatic malignancy (<i>n</i> = 57). Participants were interviewed about their demographics, health status, PCU, and end-of-life decision-making.</p><p><strong>Results: </strong>A total of 166 subjects were included (median age: 77 years; 41% females), with a 1-year median of 2 hospital admissions. Subjects with COPD and HF had low rates of PCU compared to those with malignancy (6% and 11% vs 39%, <i>p</i> < 0.01). PCU occurred exclusively in patients who had visited a specialist (cardiologist, pulmonologist, or oncologist) before study inclusion. Patients with PCU were more aware of advance directives (71% vs 38%), signed advanced orders (23% vs 3%), and shared their end-of-life decisions with others (71% vs 29%). These differences remained significant after adjustment for prior specialist visits. Independent associations with PCU were self-identifying as non-religious (adjusted OR 3.41, 95% CI 1.2-9.9), above high-school education (AOR 2.84, 95% CI 1.1-7.3), and chronic pain (aOR 2.81, 95% CI 1.11-7.14), while COPD showed the opposite (aOR 0.25, 95% CI 0.07-0.96).</p><p><strong>Conclusion: </strong>Palliative care utilization is alarmingly low among patients with HF and COPD despite significant symptom burden. Specialists should advocate for PCU as their involvement could enhance end-of-life care planning, improve patient outcomes, and address current gaps in care.</p>\",\"PeriodicalId\":22884,\"journal\":{\"name\":\"Therapeutic Advances in Respiratory Disease\",\"volume\":\"19 \",\"pages\":\"17534666251364056\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344236/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Respiratory Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17534666251364056\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Respiratory Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17534666251364056","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
背景:姑息治疗对晚期慢性疾病(ACI)的治疗至关重要,但仍未得到充分利用。目的:我们旨在评估ACIs患者姑息治疗(PCU)的患病率、相关性和结果。设计:前瞻性观察性问卷研究。方法:研究纳入住院的严重慢性阻塞性肺病患者(n = 53),晚期心力衰竭(HF;N = 56)或转移性恶性肿瘤(N = 57)。参与者接受了关于他们的人口统计、健康状况、PCU和临终决策的采访。结果:共纳入166例受试者(中位年龄:77岁;41%为女性),1年内平均住院2次。与恶性肿瘤患者相比,慢性阻塞性肺病和慢性阻塞性肺病患者的PCU率较低(分别为6%和11% vs 39%)。结论:尽管有显著的症状负担,但心衰和慢性阻塞性肺病患者的姑息治疗使用率低得惊人。专家应该提倡PCU,因为他们的参与可以加强临终关怀计划,改善病人的结果,并解决目前护理方面的差距。
Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists.
Background: Palliative care is essential for managing advanced chronic illnesses (ACI) but remains underused.
Objectives: We aimed to evaluate the prevalence, associations, and outcomes of palliative care utilization (PCU) in patients with ACIs.
Design: A prospective observational questionnaire-based study.
Methods: The study included hospitalized patients with severe COPD (n = 53), advanced heart failure (HF; n = 56), or metastatic malignancy (n = 57). Participants were interviewed about their demographics, health status, PCU, and end-of-life decision-making.
Results: A total of 166 subjects were included (median age: 77 years; 41% females), with a 1-year median of 2 hospital admissions. Subjects with COPD and HF had low rates of PCU compared to those with malignancy (6% and 11% vs 39%, p < 0.01). PCU occurred exclusively in patients who had visited a specialist (cardiologist, pulmonologist, or oncologist) before study inclusion. Patients with PCU were more aware of advance directives (71% vs 38%), signed advanced orders (23% vs 3%), and shared their end-of-life decisions with others (71% vs 29%). These differences remained significant after adjustment for prior specialist visits. Independent associations with PCU were self-identifying as non-religious (adjusted OR 3.41, 95% CI 1.2-9.9), above high-school education (AOR 2.84, 95% CI 1.1-7.3), and chronic pain (aOR 2.81, 95% CI 1.11-7.14), while COPD showed the opposite (aOR 0.25, 95% CI 0.07-0.96).
Conclusion: Palliative care utilization is alarmingly low among patients with HF and COPD despite significant symptom burden. Specialists should advocate for PCU as their involvement could enhance end-of-life care planning, improve patient outcomes, and address current gaps in care.
期刊介绍:
Therapeutic Advances in Respiratory Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of respiratory disease.